{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:55:49Z","timestamp":1790870149157,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tips.2026.08.010","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:51:36Z","timestamp":1788951096000},"page":"1079-1084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitroxyl (HNO) therapeutics: exposure control and target engagement"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0236-5743","authenticated-orcid":false,"given":"Sebasti\u00e1n A.","family":"Suarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.08.010_bb0005","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S612298","article-title":"Controlled delivery of gasotransmitters for cardiovascular therapy: molecular mechanisms, engineered platforms, and translational perspectives","volume":"21","author":"Zhu","year":"2026","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.tips.2026.08.010_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/polymscitech.5c00068","article-title":"Oral delivery systems for gasotransmitters in therapeutic applications","volume":"2","author":"Chen","year":"2026","journal-title":"Polym. Sci. Technol."},{"key":"10.1016\/j.tips.2026.08.010_bb0015","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO- in failing hearts: independence from \u03b2-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.08.010_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbc.2024.100031","article-title":"The chemistry of HNO-releasing compounds","volume":"8","author":"Smulik-izydorczyk","year":"2024","journal-title":"Redox Biochem. Chem."},{"key":"10.1016\/j.tips.2026.08.010_bb0025","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1111\/bph.15849","article-title":"Cardioprotective actions of nitroxyl donor Angeli\u2019s salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance","volume":"179","author":"Velagic","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2026.08.010_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40256-026-00788-7","article-title":"Cimlanod, a second-generation nitroxyl donor, in heart failure with reduced ejection fraction","volume":"26","author":"Dandamudi","year":"2026","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.tips.2026.08.010_bb0035","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.xphs.2024.08.027","article-title":"An unexpected degradation pathway of N-hydroxy-5-methylfuran-2-sulfonamide (BMS-986231), a pH sensitive prodrug of HNO, in a prototype formulation solution","volume":"113","author":"Huang","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tips.2026.08.010_bb0040","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.1039\/D3CC03094F","article-title":"\u03b2-Galactosidase-activated nitroxyl (HNO) donors provide insights into redox cross-talk in senescent cells","volume":"59","author":"Sawase","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.tips.2026.08.010_bb0045","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1039\/D4CC06203E","article-title":"Photo-induced nitroxyl anion\/HNO release from a nitrosyl complex of Mn(II)\u2013porphyrinate","volume":"61","author":"Saha","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.tips.2026.08.010_bb0050","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3390\/molecules29163918","article-title":"Developing photoactive coumarin-caged N-hydroxysulfonamides for generation of nitroxyl (HNO)","volume":"29","author":"Rahman","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2026.08.010_bb0055","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1039\/D2CC06134A","article-title":"A modular scaffold for triggerable and tunable nitroxyl (HNO) generation with a fluorescence reporter","volume":"59","author":"Sawase","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.tips.2026.08.010_bb0060","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1039\/D2PY01339H","article-title":"Poly(Piloty\u2019s acid): a slow releasing macromolecular HNO donor","volume":"14","author":"Swilley","year":"2023","journal-title":"Polym. Chem."},{"key":"10.1016\/j.tips.2026.08.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103915","article-title":"Differential reactivity of bacillithiol, mycothiol and glutathione with nitroxyl (HNO): structural determinants and potential biological implications","volume":"88","author":"Zeng","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2026.08.010_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ejhf.3077","article-title":"Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod","volume":"26","author":"Pellicori","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.tips.2026.08.010_bb0075","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1093\/jxb\/erae494","article-title":"Searching for nitroxyl modulators in Arabidopsis thaliana: a new paradigm of redox signaling in plants","volume":"76","author":"Suarez","year":"2025","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.tips.2026.08.010_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/jacsau.5c01230","article-title":"In vivo evaluation of liver injury and arthritis enabled by a nitroxyl-activated near-infrared fluorescence and photoacoustic dual-modality imaging probe","volume":"6","author":"Liao","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.tips.2026.08.010_bb0085","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1038\/s41467-023-40738-4","article-title":"Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming","volume":"14","author":"Palmieri","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:55Z","timestamp":1790867215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0165614726002075"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.08.010","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroxyl (HNO) therapeutics: exposure control and target engagement","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}